Technology Offerings

New Prophylactic Vaccine Targets Malignant Melanoma

Malignant Melanoma is the most rapidly increasing cancer in white populations with a doubling of rates every 10 years. Göttinger inventors identified in a study with almost 100.000 subjects the Yellow Fever Vaccine (YFV) as a prophylactic vaccine against malignant melanoma.

Further Information: PDF

MBM ScienceBridge GmbH
Phone: (0551) 30724-151

Contact
Dr. Jens-Peter Horst

Comments (0)

Write a comment